These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31122236)

  • 1. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
    Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
    BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    Ismail H; Khalid D; Waseem D; Ijaz MU; Dilshad E; Haq IU; Bhatti MZ; Anwaar S; Ahmed M; Saleem S
    PLoS One; 2023; 18(11):e0286349. PubMed ID: 37910530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine: a potential multipotent natural product to combat Alzheimer's disease.
    Ji HF; Shen L
    Molecules; 2011 Aug; 16(8):6732-40. PubMed ID: 21829148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating Neuroprotective Potential of Berberine, Levetiracetam and their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.
    Singh A; Dhaneshwar S; Mazumder A
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):182-190. PubMed ID: 34515019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research.
    Ye M; Fu S; Pi R; He F
    J Pharm Pharmacol; 2009 Jul; 61(7):831-7. PubMed ID: 19589224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer's disease models: a systematic review and meta-analysis.
    Liu JY; Dai Y; He YX; Lin L
    Front Pharmacol; 2023; 14():1301102. PubMed ID: 38293672
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.
    Akbar M; Shabbir A; Rehman K; Akash MSH; Shah MA
    J Food Biochem; 2021 Oct; 45(10):e13936. PubMed ID: 34523148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.
    Hussien HM; Abd-Elmegied A; Ghareeb DA; Hafez HS; Ahmed HEA; El-Moneam NA
    Food Chem Toxicol; 2018 Jan; 111():432-444. PubMed ID: 29170048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical profiling of berberine-enriched extract in aluminum chloride induced oxidative damage and neuroinflammation.
    Akash MSH; Akbar M; Rehman K; Shah MA; Panichayupakaranant P; Imran M; Assiri MA
    Environ Sci Pollut Res Int; 2023 Aug; 30(36):85263-85275. PubMed ID: 37380861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to intracerebroventricular injection of streptozotocin.
    de Oliveira JS; Abdalla FH; Dornelles GL; Palma TV; Signor C; da Silva Bernardi J; Baldissarelli J; Lenz LS; de Oliveira VA; Chitolina Schetinger MR; Melchiors Morsch VM; Rubin MA; de Andrade CM
    Psychopharmacology (Berl); 2019 Feb; 236(2):641-655. PubMed ID: 30377748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
    Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
    Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis.
    Dan L; Hao Y; Li J; Wang T; Zhao W; Wang H; Qiao L; Xie P
    Front Pharmacol; 2023; 14():1287750. PubMed ID: 38259291
    [No Abstract]   [Full Text] [Related]  

  • 15. Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death.
    de Oliveira JS; Abdalla FH; Dornelles GL; Adefegha SA; Palma TV; Signor C; da Silva Bernardi J; Baldissarelli J; Lenz LS; Magni LP; Rubin MA; Pillat MM; de Andrade CM
    Neurotoxicology; 2016 Dec; 57():241-250. PubMed ID: 27746125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies.
    Hosseini L; Mahmoudi J; Pashazadeh F; Salehi-Pourmehr H; Sadigh-Eteghad S
    J Mol Neurosci; 2021 Jul; 71(7):1425-1435. PubMed ID: 33907963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine: Pathways to protect neurons.
    Lin X; Zhang N
    Phytother Res; 2018 Aug; 32(8):1501-1510. PubMed ID: 29732634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine: A Traditional Natural Product With Novel Biological Activities.
    Hou Q; He WJ; Wu YS; Hao HJ; Xie XY; Fu XB
    Altern Ther Health Med; 2020 Jul; 26(S2):20-27. PubMed ID: 31634873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
    Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
    Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells - In vitro models simulating Alzheimer's disease pathology.
    Wong LR; Tan EA; Lim MEJ; Shen W; Lian XL; Wang Y; Chen L; Ho PC
    Life Sci; 2021 Oct; 282():119824. PubMed ID: 34265361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.